Cassady Wealth & Retirement Planning LLC Acquires 4,281 Shares of SPDR S&P Biotech ETF $XBI

Cassady Wealth & Retirement Planning LLC increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.4% during the first quarter, Holdings Channel reports. The fund owned 21,141 shares of the exchange traded fund’s stock after acquiring an additional 4,281 shares during the quarter. SPDR S&P Biotech ETF comprises about 1.4% of Cassady Wealth & Retirement Planning LLC’s holdings, making the stock its 29th biggest holding. Cassady Wealth & Retirement Planning LLC’s holdings in SPDR S&P Biotech ETF were worth $2,776,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in XBI. Avoro Capital Advisors LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $256,053,000. Wells Fargo & Company MN boosted its position in SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after purchasing an additional 1,536,122 shares during the period. OMERS ADMINISTRATION Corp increased its holdings in shares of SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares during the last quarter. Morgan Stanley increased its holdings in shares of SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after purchasing an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $147.91 on Thursday. The company’s 50-day moving average is $145.48 and its 200-day moving average is $134.07. The firm has a market capitalization of $9.73 billion, a PE ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a fifty-two week low of $84.39 and a fifty-two week high of $165.71.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.